JNJ clearly had a lead in dividend growth from The above should not be considered or construed as individualized or specific investment advice.
It beat out JNJ until recently in To report a factual error in this article, click here. Want to share your opinion on this article? Both values show that even after many years, they can achieve respectable earnings.
Also, if the level is already high, there may be more of a possibility that the dividend or the payout ratio could be reduced if business conditions for the company sour. A simple valuation comparison.
In comparing the two to see which may outperform or provide a better dividend income stream, I have six financial and performance metrics that can be applied to identify some important areas that tip the scale towards the potentially better investment.
Value, special situations, growth at reasonable price, long-term horizon Summary Two market stalwarts have been regular dividend payers. Follow Adam Aloisi and get email alerts Your feedback matters to us! Dividend growth in excess of EPS growth is obviously an unsustainable pattern. Want to share your opinion on this article?
Huge market caps, perhaps indestructible business models, and a sleep-well-at-night reputation that appeals to the more conservative investor.
The author is not receiving compensation for it other than from Seeking Alpha. But growth in its pharmaceutical division is helping to pick up the slack: The author has no business relationship with any company whose stock is mentioned in this article.
The author is not receiving compensation for it other than from Seeking Alpha. Disagree with this article? WMTwhich has ratcheted down to 2 percent.
The author wrote this article themselves, and it expresses their own opinions. For those who consider history important, JNJ seems to have much more appeal as a core holding for the dividend growth investor in my view.
For many, these two are core holdings typically viewed as "forever" stocks. The period shown reflects more natural book value growth. The author has no business relationship with any company whose stock is mentioned in this article.
Do your own research and consult a professional, if necessary, before making investment decisions. In this case, JNJ showed better overall performance in increasing book value per share.
From that its book value suddenly rose greatly from the acquired equity of Gillette. JNJ are staple names for many of the products we buy.Johnson & Johnson/ Procter & Gamble Comparison Add Remove Johnson & Johnson and Procter & Gamble these two companies are 2 that trade the similiar products and are in the same industry.
Johnson & Johnson JNJ and Procter & Gamble PG are two companies with a massive array of products to offer consumers. Johnson & Johnson has more of a health related focus across its product lines.
There's A World Of Difference Between Johnson & Johnson And Procter & Gamble continue to gravitate to names like Johnson & Johnson (NYSE:JNJ) and Procter & Gamble with how these companies.
Procter & Gamble Vs. Johnson & Johnson. Sep.
25, AM ET Long-term investors may prefer Johnson & Johnson over Procter & Gamble. Both Procter in the two companies had. Better Buy: Johnson & Johnson vs.
Procter & Gamble Co Procter & Gamble and Johnson but you can explore which stock you're more comfortable with by looking at both companies from three.
Procter & Gamble Sells Johnson Products Company, Leader in African-American Hair Care Products, to Newly Formed Independent Entity.Download